Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 328

1.

Giant Mesenteric Lipoma Causing Small Bowel Volvulus: A Case Report.

Suga Y, Abdi E, Bekele M.

Ethiop J Health Sci. 2019 Jul;29(4):529-532. doi: 10.4314/ejhs.v29i4.15.

2.

Unique reticular hyperkeratotic eruptions seen in a patient with Darier's disease and attention deficit hyperactivity disorder.

Yoshikawa T, Takeichi T, Suga Y, Kitajima Y, Akiyama M.

J Eur Acad Dermatol Venereol. 2019 Aug 20. doi: 10.1111/jdv.15892. [Epub ahead of print] No abstract available.

PMID:
31430409
3.

Pharmacokinetics and tissue distribution of 3,4-diaminopyridine in rats.

Ishida N, Kondo Y, Chikano Y, Kobayashi-Nakade E, Suga Y, Ishizaki J, Komai K, Matsushita R.

Biopharm Drug Dispos. 2019 Sep;40(8):294-301. doi: 10.1002/bdd.2203.

PMID:
31419315
4.

A Previously Unknown Drug-Drug Interaction Is Suspected in Delayed Elimination of Plasma Methotrexate in High-Dose Methotrexate Therapy.

Ishizaki J, Nakano C, Kitagawa K, Suga Y, Sai Y.

Ann Pharmacother. 2019 Aug 15:1060028019870445. doi: 10.1177/1060028019870445. [Epub ahead of print]

PMID:
31416331
5.

Ultrasonography surveillance improves prognosis of patients with hepatocellular carcinoma.

Yamago H, Hiraoka A, Murakami T, Izumoto H, Ueki H, Ochi M, Aibiki T, Okudaira T, Iwasaki R, Suga Y, Mori K, Miyata H, Tsubouchi E, Kishida M, Hirooka M, Abe M, Matsuura B, Ninomiya T, Hiasa Y, Michitaka K.

Mol Clin Oncol. 2019 Sep;11(3):325-330. doi: 10.3892/mco.2019.1888. Epub 2019 Jun 25.

6.

The Respimat® Soft Mist Inhaler: Implications of Drug Delivery Characteristics for Patients.

Iwanaga T, Tohda Y, Nakamura S, Suga Y.

Clin Drug Investig. 2019 Nov;39(11):1021-1030. doi: 10.1007/s40261-019-00835-z. Review.

PMID:
31377981
7.

A nationwide survey of hospital pharmacist interventions to improve polypharmacy for patients with cancer in palliative care in Japan.

Uchida M, Suzuki S, Sugawara H, Suga Y, Kokubun H, Uesawa Y, Nakagawa T, Takase H.

J Pharm Health Care Sci. 2019 Jul 3;5:14. doi: 10.1186/s40780-019-0143-5. eCollection 2019.

8.

Clinical Characteristics Associated With Lenvatinib-induced Fistula and Tumor-related Bleeding in Patients With Thyroid Cancer.

Staub Y, Nishiyama A, Suga Y, Fujita M, Matsushita R, Yano S.

Anticancer Res. 2019 Jul;39(7):3871-3878. doi: 10.21873/anticanres.13537.

PMID:
31262915
9.

Efficacy and Safety of Nivolumab in Patients with Advanced Non-small-cell Lung Cancer and Poor Performance Status.

Katsura H, Suga Y, Araya T, Kita T, Yoneda T, Tanaka N, Kawabata A, Ishita S, Mase H.

J Cancer. 2019 May 19;10(10):2139-2144. doi: 10.7150/jca.31217. eCollection 2019.

10.

Analyses of Respiratory Depression Associated with Opioids in Cancer Patients Based on the Japanese Adverse Drug Event Report Database.

Sugawara H, Uchida M, Suzuki S, Suga Y, Uesawa Y, Nakagawa T, Takase H.

Biol Pharm Bull. 2019;42(7):1185-1191. doi: 10.1248/bpb.b19-00105.

11.

Affirmative answers on loco-check as a predictor of health-related quality of life and locomotive syndrome progression in the elderly: A cross-sectional study.

Shigematsu H, Tanaka M, Munemoto M, Kawasaki S, Iwata E, Okuda A, Masuda K, Yamamoto Y, Suga Y, Tanaka Y.

Mod Rheumatol. 2019 Jun 13:1-6. doi: 10.1080/14397595.2019.1621459. [Epub ahead of print]

PMID:
31116048
12.

Current Status of Adverse Events Related with Opioid Analgesics in Japan: Assessment Based on Japanese Adverse Drug Event Report Database.

Suga Y, Uchida M, Suzuki S, Sugawara H, Torigoe K, Futamura A, Uesawa Y, Nakagawa T, Takase H.

Biol Pharm Bull. 2019;42(5):801-806. doi: 10.1248/bpb.b18-00997.

13.

Incidence and risk factors of neonatal hypoglycemia after ritodrine therapy in premature labor: a retrospective cohort study.

Shimokawa S, Sakata A, Suga Y, Isoda K, Itai S, Nagase K, Shimada T, Sai Y.

J Pharm Health Care Sci. 2019 Apr 16;5:7. doi: 10.1186/s40780-019-0137-3. eCollection 2019.

14.

A Nationwide Survey of Community Pharmacist Contributions to Polypharmacy in Opioid-Using and Non-using Cancer Patients in Japan.

Suzuki S, Uchida M, Suga Y, Sugawara H, Kokubun H, Uesawa Y, Nakagawa T, Takase H.

Biol Pharm Bull. 2019 Jul 1;42(7):1164-1171. doi: 10.1248/bpb.b19-00043. Epub 2019 Apr 17.

15.

Combination of Resection and Ablative Treatment for Hepatocellular Carcinoma: Usefulness of Complementary Radiofrequency Ablation.

Hiraoka A, Hirooka M, Ochi H, Koizumi Y, Izumoto H, Ueki H, Tsuruta M, Ono A, Yoshino T, Aibiki T, Okudaira T, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Kishida M, Tsubouchi E, Abe M, Matsuura B, Ninomiya T, Joko K, Kawasaki H, Hiasa Y, Michitaka K.

Oncology. 2019;96(5):242-251. doi: 10.1159/000496225. Epub 2019 Mar 20.

PMID:
30893698
16.

Relationship between the Degrees of Itch and Serum Lipocalin-2 Levels in Patients with Psoriasis.

Aizawa N, Ishiuji Y, Tominaga M, Sakata S, Takahashi N, Yanaba K, Umezawa Y, Asahina A, Kimura U, Suga Y, Takamori K, Nakagawa H.

J Immunol Res. 2019 Jan 21;2019:8171373. doi: 10.1155/2019/8171373. eCollection 2019.

17.

Palonosetron on Days 1 and 5 Versus Granisetron Daily (Days 1-5) in Germ Cell Tumour Therapy.

Shimura Y, Izumi K, Itai S, Iwamoto H, Yaegashi H, Suga Y, Shimada T, Mizokami A, Sai Y.

In Vivo. 2019 Mar-Apr;33(2):643-647. doi: 10.21873/invivo.11522.

18.

An automated microliter-scale high-throughput screening system (MSHTS) for real-time monitoring of protein aggregation using quantum-dot nanoprobes.

Sasaki R, Tainaka R, Ando Y, Hashi Y, Deepak HV, Suga Y, Murai Y, Anetai M, Monde K, Ohta K, Ito I, Kikuchi H, Oshima Y, Endo Y, Nakao H, Sakono M, Uwai K, Tokuraku K.

Sci Rep. 2019 Feb 22;9(1):2587. doi: 10.1038/s41598-019-38958-0.

19.

Easy surveillance of muscle volume decline in chronic liver disease patients using finger-circle (yubi-wakka) test.

Hiraoka A, Izumoto H, Ueki H, Yoshino T, Aibiki T, Okudaira T, Yamago H, Suga Y, Iwasaki R, Tomida H, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Hirooka M, Abe M, Matsuura B, Hiasa Y, Michitaka K.

J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):347-354. doi: 10.1002/jcsm.12392. Epub 2019 Feb 21.

20.

Prediction of risk of falls based on handgrip strength in chronic liver disease patients living independently.

Hiraoka A, Tamura R, Oka M, Izumoto H, Ueki H, Tsuruta M, Yoshino T, Ono A, Aibiki T, Okudaira T, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Hirooka M, Abe M, Matsuura B, Hiasa Y, Kino T, Yamamoto K, Michitaka K.

Hepatol Res. 2019 Jul;49(7):823-829. doi: 10.1111/hepr.13322. Epub 2019 Mar 19.

PMID:
30770617
21.

Multiday corticosteroids in cancer chemotherapy delay the diagnosis of and antimicrobial administration for febrile neutropenia: a double-center retrospective study.

Uda H, Suga Y, Toriba E, Staub AY, Shimada T, Sai Y, Kawahara M, Matsusita R.

J Pharm Health Care Sci. 2019 Feb 4;5:3. doi: 10.1186/s40780-018-0130-2. eCollection 2019.

22.

Skin advanced glycation end products as biomarkers of photosensitivity in schizophrenia.

Tani E, Ohnuma T, Hirose H, Nakayama K, Mao W, Nakadaira M, Orimo N, Yamashita H, Takebayashi Y, Miki Y, Katsuta N, Nishimon S, Hasegawa T, Komiyama E, Suga Y, Ikeda S, Arai H.

Int J Methods Psychiatr Res. 2019 Mar;28(1):e1769. doi: 10.1002/mpr.1769. Epub 2019 Jan 31.

PMID:
30701623
23.

Severe genital frostbite due to improper use of an aerosol spray: A case of raising awareness of the risk of skin necrosis with aerosol propellants.

Kurosaki Y, Negi O, Takamori K, Suga Y.

J Dermatol. 2019 Jul;46(7):e247-e248. doi: 10.1111/1346-8138.14803. Epub 2019 Jan 31. No abstract available.

PMID:
30701580
24.

Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells.

Kinehara Y, Nagatomo I, Koyama S, Ito D, Nojima S, Kurebayashi R, Nakanishi Y, Suga Y, Nishijima-Futami Y, Osa A, Nakatani T, Kato Y, Nishide M, Hayama Y, Higashiguchi M, Morimura O, Miyake K, Kang S, Minami T, Hirata H, Iwahori K, Takimoto T, Takamatsu H, Takeda Y, Hosen N, Hoshino S, Shintani Y, Okumura M, Kumagai T, Nishino K, Imamura F, Nakatsuka SI, Kijima T, Kida H, Kumanogoh A.

JCI Insight. 2018 Dec 20;3(24). pii: 123093. doi: 10.1172/jci.insight.123093.

25.

Effect of coadministration of rifampicin on the pharmacokinetics of linezolid: clinical and animal studies.

Hashimoto S, Honda K, Fujita K, Miyachi Y, Isoda K, Misaka K, Suga Y, Kato S, Tsuchiya H, Kato Y, Okajima M, Taniguchi T, Shimada T, Sai Y.

J Pharm Health Care Sci. 2018 Nov 12;4:27. doi: 10.1186/s40780-018-0123-1. eCollection 2018.

26.

Structure-inspired design of a sphingolipid mimic sphingosine-1-phosphate receptor agonist from a naturally occurring sphingomyelin synthase inhibitor.

Swamy MMM, Murai Y, Ohno Y, Jojima K, Kihara A, Mitsutake S, Igarashi Y, Yu J, Yao M, Suga Y, Anetai M, Monde K.

Chem Commun (Camb). 2018 Nov 8;54(90):12758-12761. doi: 10.1039/c8cc05595e.

PMID:
30362470
27.

Asymptomatic abdominal aortic stenosis detected by unenhanced computed tomography before angiography in acute myocardial infarction.

Suga T, Hatori T, Suga Y, Yoshida M, Oyama K.

Clin Case Rep. 2018 Aug 29;6(10):2021-2022. doi: 10.1002/ccr3.1780. eCollection 2018 Oct.

28.

Onychomycosis caused by Scopulariopsis brevicaulis: The third documented case in Japan.

Kimura U, Hiruma M, Kano R, Matsumoto T, Takamori K, Suga Y.

J Dermatol. 2019 May;46(5):e167-e168. doi: 10.1111/1346-8138.14677. Epub 2018 Oct 10. No abstract available.

PMID:
30303252
29.

Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients.

Osa A, Uenami T, Koyama S, Fujimoto K, Okuzaki D, Takimoto T, Hirata H, Yano Y, Yokota S, Kinehara Y, Naito Y, Otsuka T, Kanazu M, Kuroyama M, Hamaguchi M, Koba T, Futami Y, Ishijima M, Suga Y, Akazawa Y, Machiyama H, Iwahori K, Takamatsu H, Nagatomo I, Takeda Y, Kida H, Akbay EA, Hammerman PS, Wong KK, Dranoff G, Mori M, Kijima T, Kumanogoh A.

JCI Insight. 2018 Oct 4;3(19). pii: 59125. doi: 10.1172/jci.insight.59125.

30.

[A Case of Mediastinal Small Cell Lung Cancer in a Patient Receiving Mechanical Ventilation Who Was Successfully Treated with Chemotherapy and Finally Extubated].

Koba T, Hirata H, Kijima T, Naito Y, Hamaguchi M, Suga Y, Kuroyama M, Koyama S, Iwahori K, Takimoto T, Nagatomo I, Takeda Y, Kida H.

Gan To Kagaku Ryoho. 2018 Sep;45(9):1335-1337. Japanese.

PMID:
30237376
31.

[Laser Therapies for Onychomycosis in Japan].

Kimura U, Suga Y.

Med Mycol J. 2018;59(3):J45-J49. doi: 10.3314/mmj.18.007. Review. Japanese.

32.

Risk factors for oxaliplatin-induced vascular pain in patients with colorectal cancer and comparison of the efficacy of preventive methods.

Suga Y, Ikeda N, Maeda M, Staub AY, Shimada T, Yonezawa M, Kitade H, Katsura H, Okada M, Ishizaki J, Sai Y, Matsushita R.

J Pharm Health Care Sci. 2018 Aug 7;4:18. doi: 10.1186/s40780-018-0117-z. eCollection 2018.

33.

Protein expression patterns in cancer-associated fibroblasts and cells undergoing the epithelial-mesenchymal transition in ovarian cancers.

Fukagawa D, Sugai T, Osakabe M, Suga Y, Nagasawa T, Itamochi H, Sugiyama T.

Oncotarget. 2018 Jun 8;9(44):27514-27524. doi: 10.18632/oncotarget.25518. eCollection 2018 Jun 8.

34.

Bepotastine besilate downregulates the expression of nerve elongation factors in normal human epidermal keratinocytes.

Kamata Y, Sakaguchi A, Umehara Y, Suga Y, Ogawa H, Tominaga M, Takamori K.

J Dermatol Sci. 2018 Apr 23. pii: S0923-1811(18)30186-5. doi: 10.1016/j.jdermsci.2018.04.012. [Epub ahead of print] No abstract available.

PMID:
29730173
35.

Design, synthesis and biological evaluation of novel 7-azaspiro[3.5]nonane derivatives as GPR119 agonists.

Matsuda D, Kawamura M, Kobashi Y, Shiozawa F, Suga Y, Fusegi K, Nishimoto S, Kimura K, Miyoshi M, Takayama N, Kakinuma H, Ohtake N.

Bioorg Med Chem. 2018 May 1;26(8):1832-1847. doi: 10.1016/j.bmc.2018.02.032. Epub 2018 Feb 20.

PMID:
29486951
36.

Monitoring of immunoglobulin A antibodies to epidermal and tissue transglutaminases over an 18-month period in a Japanese patient with dermatitis herpetiformis.

Kurosaki Y, Suga Y, Negi O, Takamori K, Ishii N, Makino T, Shimizu T, Hashimoto T.

J Dermatol. 2018 Aug;45(8):e211-e212. doi: 10.1111/1346-8138.14264. Epub 2018 Feb 21. No abstract available.

PMID:
29464845
37.

Optimisation of antithrombin resistance assay as a practical clinical laboratory test: Development of prothrombin activator using factors Xa/Va and automation of assay.

Tamura S, Suga Y, Tanamura M, Murata-Kawakami M, Takagi Y, Hottori Y, Kakihara M, Suzuki S, Takagi A, Kojima T.

Int J Lab Hematol. 2018 Jun;40(3):312-319. doi: 10.1111/ijlh.12786. Epub 2018 Feb 13.

PMID:
29436777
38.

Connective Tissue Growth Factor Neutralization Aggravates the Psoriasis Skin Lesion: The Analysis of Psoriasis Model Mice and Patients.

Hayakawa K, Ikeda K, Fujishiro M, Yoshida Y, Hirai T, Tsushima H, Miyashita T, Morimoto S, Suga Y, Takamori K, Ogawa H, Sekigawa I.

Ann Dermatol. 2018 Feb;30(1):47-53. doi: 10.5021/ad.2018.30.1.47. Epub 2017 Dec 26.

39.

Trial of hyperthermic treatment for Bowen's disease with disposable chemical pocket warmers: A report of two cases.

Kurihara M, Kimura U, Hiruma M, Takamori K, Suga Y.

J Dermatol. 2018 May;45(5):e136-e137. doi: 10.1111/1346-8138.14166. Epub 2017 Dec 14. No abstract available.

PMID:
29239019
40.

Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis.

Hiraoka A, Michitaka K, Kiguchi D, Izumoto H, Ueki H, Kaneto M, Kitahata S, Aibiki T, Okudaira T, Tomida H, Miyamoto Y, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Kohgami S, Hirooka M, Tokumoto Y, Abe M, Matsuura B, Hiasa Y.

Eur J Gastroenterol Hepatol. 2017 Dec;29(12):1416-1423. doi: 10.1097/MEG.0000000000000986.

PMID:
29016470
41.

Effect of availability of video laryngoscopy on the use of fiberoptic intubation in school-aged children with microtia.

Kondo I, Kobayashi H, Suga Y, Suzuki A, Kiyama S, Uezono S.

Paediatr Anaesth. 2017 Nov;27(11):1115-1119. doi: 10.1111/pan.13238. Epub 2017 Sep 20.

PMID:
28940719
42.

Gemcitabine and docetaxel in a patient with primary ovarian leiomyosarcoma: a case report and review of literature.

Furutake Y, Fukagawa T, Suga Y, Nagasawa T, Sato S, Omi H, Kagabu M, Chiba A, Shoji T, Takeuchi S, Sugai T, Itamochi H, Sugiyama T.

Int Cancer Conf J. 2017 Sep 11;7(1):11-15. doi: 10.1007/s13691-017-0309-7. eCollection 2018 Jan.

43.

Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents.

Kurosaki Y, Takamori K, Suga Y.

Indian J Dermatol. 2017 Jul-Aug;62(4):441. doi: 10.4103/ijd.IJD_97_17. No abstract available.

44.

Inhibition of Aurora Kinase A Synergistically Enhances Cytotoxicity in Ovarian Clear Cell Carcinoma Cell Lines Induced by Cisplatin: A Potential Treatment Strategy.

Chiba Y, Sato S, Itamochi H, Yoshino N, Fukagawa D, Kawamura H, Suga Y, Kojima-Chiba A, Muraki Y, Sugai T, Sugiyama T.

Int J Gynecol Cancer. 2017 Oct;27(8):1666-1674. doi: 10.1097/IGC.0000000000001081.

PMID:
28786875
45.

Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologics.

Kanekura T, Seishima M, Honma M, Etou T, Eto H, Okuma K, Okubo Y, Yamaguchi Y, Kambara T, Mabuchi T, Suga Y, Morita A, Yamanishi K, Tsuruta D, Itoh K, Yamaji K, Ikeda S.

J Dermatol. 2017 Dec;44(12):1353-1359. doi: 10.1111/1346-8138.13975. Epub 2017 Aug 3.

PMID:
28771892
46.

Determinants of Awareness and Practice of Breast Self Examination Among Rural Women in Trichy, Tamil Nadu.

Kumarasamy H, Veerakumar AM, Subhathra S, Suga Y, Murugaraj R.

J Midlife Health. 2017 Apr-Jun;8(2):84-88. doi: 10.4103/jmh.JMH_79_16.

47.

Spontaneous coronary artery dissection with a collateral vessel.

Suga T, Hatori T, Oyama K, Suga Y, Imai K, Kitahara Y.

Cardiovasc Interv Ther. 2018 Jul;33(3):295-296. doi: 10.1007/s12928-017-0480-y. Epub 2017 Jun 22. No abstract available.

PMID:
28643216
48.

Lentinan diminishes apoptotic bodies in the ileal crypts associated with S-1 administration.

Suga Y, Takehana K.

Int Immunopharmacol. 2017 Sep;50:55-60. doi: 10.1016/j.intimp.2017.06.012. Epub 2017 Jun 17.

PMID:
28628771
49.

A combination of low-dose systemic etretinate and topical calcipotriol/betamethasone dipropionate treatment for hyperkeratosis and itching in Olmsted syndrome associated with a TRPV3 mutation.

Takeichi T, Tsukamoto K, Okuno Y, Kojima D, Kono M, Suga Y, Akiyama M.

J Dermatol Sci. 2017 Oct;88(1):144-146. doi: 10.1016/j.jdermsci.2017.05.012. Epub 2017 May 29. No abstract available.

PMID:
28587736
50.

A Child with Epidermolytic Ichthyosis from a Parent with Epidermolytic Nevus: Risk Evaluation of Transmission from Mosaic to Germline.

Kono M, Suga Y, Akashi T, Ito Y, Takeichi T, Muro Y, Akiyama M.

J Invest Dermatol. 2017 Sep;137(9):2024-2026. doi: 10.1016/j.jid.2017.04.036. Epub 2017 May 19. No abstract available.

Supplemental Content

Support Center